Bajaj Healthcare Limited has disclosed the conversion of convertible warrants into equity shares by a promoter group member under SEBI regulations. Anil Champalal Jain, Managing Director and member of the promoter group, converted 4,55,074 convertible warrants into equity shares on March 18, 2026.

Warrant Conversion Details

The conversion represents a strategic move by the promoter group to increase their equity participation in the company. The disclosure was filed under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as required for substantial acquisitions.

Impact on Share Capital Structure

The warrant conversion has resulted in an expansion of the company's equity base. The total number of equity shares increased significantly following the allotment of new shares to the promoter group member.

Regulatory Compliance

The transaction was completed through the allotment of equity shares pursuant to the conversion of convertible warrants. Anil Champalal Jain's total holding, including the converted shares, now stands at 19,36,544 equity shares, representing 5.75% of the company's total voting capital.

The disclosure indicates that no shares were held under encumbrance categories such as pledge, lien, or non-disposal undertaking. The conversion was processed on March 18, 2026, with the regulatory filing submitted on March 20, 2026.

Market Presence

Bajaj Healthcare Limited's shares are listed on both BSE Limited and National Stock Exchange of India Limited. The company operates under BSE Scrip Code 539872 and NSE Symbol BAJAJHCARE, providing investors with trading access across both major Indian stock exchanges.

Bajaj Healthcare promoter Sajankumar Rameshwarlal Bajaj has converted 4,55,074 convertible warrants into equity shares, as disclosed in a regulatory filing under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The conversion took place on 18th March 2026, resulting in the allotment of an equivalent number of equity shares.

Shareholding Changes

The warrant conversion has altered the promoter's shareholding structure in the company. Prior to the conversion, Sajankumar Rameshwarlal Bajaj held 1,18,70,700 equity shares representing 37.59% of the total share capital. Additionally, he held 4,55,074 convertible warrants, bringing his total holding to 1,23,25,774 shares or 39.03% on a diluted basis.

Impact on Share Capital

The conversion has expanded Bajaj Healthcare Limited's total equity share capital. The company's equity base increased from 3,15,83,252 shares to 3,36,62,661 shares, each carrying a face value of Rs. 5. This expansion represents the conversion of all outstanding warrants held by the promoter.

Regulatory Compliance

The disclosure was made by Sajankumar Rameshwarlal Bajaj in his capacity as Chairman and Managing Director of the company. As a promoter, he is required to disclose substantial changes in shareholding under Regulation 29(1) of SEBI regulations. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited.

Transaction Details

The warrant conversion represents a straightforward corporate action where existing convertible securities were exercised into equity shares. The mode of acquisition was through allotment of equity shares pursuant to the conversion of convertible warrants. No encumbrances, pledges, or liens were reported on the shares before or after the conversion.